Structure Therapeutics (GPCR) Earnings Date, Estimates & Call Transcripts $22.34 -1.41 (-5.94%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$22.50 +0.16 (+0.72%) As of 03/3/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Structure Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 8Before Market OpensEstimatedActual EPS (Feb. 27) -$0.22 Beat By $0.01 Consensus EPS (Feb. 27) -$0.23 Structure Therapeutics posted Q4 2024 earnings on February 27, 2025, reporting an EPS of -$0.22, which beat analysts' consensus estimates of -$0.23 by $0.01. With a trailing EPS of -$0.79, Structure Therapeutics' earnings are expected to grow next year, from ($0.82) to ($0.62) per share. GPCR Upcoming EarningsStructure Therapeutics' next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Structure Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Structure Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGPCR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GPCR Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Structure Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.24-$0.18-$0.21Q2 20252-$0.26-$0.18-$0.22Q3 20252-$0.28-$0.24-$0.26Q4 20252-$0.31-$0.22-$0.27FY 20258($1.09)($0.82)($0.96) Structure Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------2/27/2025Q4 2024-$0.23-$0.22+$0.01-$0.22--8/8/2024--$0.23-$0.18+$0.05-$0.18--5/9/2024Q1 2024-$0.21-$0.19+$0.02-$0.19--3/8/2024Q4 2023-$0.21-$0.17+$0.04-$0.17--11/14/2023Q3 2023-$0.22-$0.21+$0.01-$0.21--8/10/2023Q2 2023-$0.19-$0.20 -$0.01-$0.20--5/11/2023Q1 2023-$0.34-$0.25+$0.09-$0.25-- Structure Therapeutics Earnings - Frequently Asked Questions When is Structure Therapeutics's earnings date? Structure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on GPCR's earnings history. Did Structure Therapeutics beat their earnings estimates last quarter? In the previous quarter, Structure Therapeutics (NASDAQ:GPCR) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.01. Learn more on analysts' earnings estimate vs. GPCR's actual earnings. How much profit does Structure Therapeutics generate each year? Structure Therapeutics (NASDAQ:GPCR) has a recorded net income of -$89.62 million. GPCR has generated -$0.79 earnings per share over the last four quarters. What is Structure Therapeutics's EPS forecast for next year? Structure Therapeutics's earnings are expected to grow from ($0.82) per share to ($0.62) per share in the next year. More Earnings Resources from MarketBeat Related Companies TG Therapeutics Earnings Date SpringWorks Therapeutics Earnings Date Organon & Co. Earnings Date Ultragenyx Pharmaceutical Earnings Date PTC Therapeutics Earnings Date ADMA Biologics Earnings Date Avidity Biosciences Earnings Date Zai Lab Earnings Date Biohaven Earnings Date Alvotech Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of EarningsThe Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance? This page (NASDAQ:GPCR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Structure Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Structure Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GPCR Stock Alerts